Oramed Pharmaceuticals
ORMP
#8967
Rank
HK$1.06 B
Marketcap
HK$26.82
Share price
-2.27%
Change (1 day)
49.78%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): HK$6.33

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$6.32. In 2024 the company made an earnings per share (EPS) of -HK$3.74 a decrease over its 2023 EPS that were of HK$1.09.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$6.33-269.12%
2024-HK$3.74-442.86%
2023HK$1.09-114.89%
2022-HK$7.3320.51%
2021-HK$6.0839.29%
2020-HK$4.37-31.71%
2019-HK$6.39-4.65%
2018-HK$6.718.86%
2017-HK$6.16-9.2%
2016-HK$6.7829.85%
2015-HK$5.228.06%
2014-HK$4.835.08%
2013-HK$4.603.51%
2012-HK$4.44137.5%
2011-HK$1.87-60%
2010-HK$4.68-0%
2009-HK$4.68-16.67%
2008-HK$5.61-25%
2007-HK$7.49700%
2006-HK$0.94303.56%
2005-HK$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-HK$46.31-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$27.39 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$28.89 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-HK$2.34-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-HK$1.48-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA